Péter Adorján has joined the Board of Centogene, extending it to three people.
As Chief Business Development Officer, Adorján is in charge of expanding the portfolios of the Rostock, Germany-based genetic testing laboratory for rare hereditary diseases and bringing them to market.
Adorján has nearly two decades of broad experience across the healthcare and IT industries.
After earning a PhD in informatics, focusing on computational neuroscience and machine learning, he joined Epigenomics, where he established and led the Biostatistics Department as VP Information Sciences and later took over as VP Manufacturing. In these positions he helped create multi-year joint ventures with large pharmaceutical companies as well as in IVD product development.
He then joined McKinsey & Company as a Senior Consultant in the Business Technology Office, later becoming Global Competence Centre Manager and Director Portfolio at T-Systems and Unisys.
